grant

Developing autologous iPSC-RPE based IND for AMD patients

Organization NATIONAL EYE INSTITUTELocation UNITED STATES
NIHUS FederalResearch GrantFY2025AcuteAirAnimal ModelAnimal Models and Related StudiesAnimalsAtrophic AMDAtrophic age-related macular degenerationAutologousBiotechBiotechnologyBlebBlisterBody TissuesBullaBullous LesionCell TherapyChronicClinicalClinical ProtocolsCo-cultureCocultivationCocultureCoculture TechniquesCollaborationsDry AMDDysembryomaEarly-Stage Clinical TrialsEyeEyeballFDA approvedFamily suidaeGoalsHistologicHistologicallyHumanIND FilingIND applicationIND packageIND submissionIRBIRBsImmunocompromisedImmunocompromised HostImmunocompromised PatientImmunosuppressed HostInjectionsInstitutional Review BoardsInvestigational New Drug ApplicationLiquid substanceModelingModern ManNational Institutes of HealthNon-exudative age-related macular degenerationNonexudative age-related macular degenerationOncogenesisOperative ProceduresOperative Surgical ProceduresOrganOtomyPatientsPhasePhase 1 Clinical TrialsPhase I Clinical TrialsPhotoreceptor CellPhotoreceptorsPhotosensitive CellPigsProceduresProcessProductionProgenitor CellsProtocolProtocols documentationRetinaSafetySalineSaline SolutionSamplingSkinSuidaeSurgicalSurgical InterventionsSurgical ProcedureSurgical incisionsSwineTechnologyTeratoid TumorTeratomaTestingTherapeuticTimeTissuesTransplantationUnited States National Institutes of HealthVesicationVisual ReceptorVitrectomyWorkcell based interventioncell mediated interventioncell mediated therapiescell-based therapeuticcell-based therapycellular therapeuticcellular therapyclinical centerdry age-related macular degenerationefficacy testingfluidfull scale manufacturinghuman subjectiPSiPSCiPSCsimmunosuppressed patientincisioninduced pluripotent cellinduced pluripotent stem cellinducible pluripotent cellinducible pluripotent stem celllarge scale manufacturinglarge scale productionliquidmass productionmodel of animalparticipant enrollmentpatient enrollmentphase 1/2a trialphase I protocolphase I/IIa trialporcinepre-clinicalpre-clinical efficacypre-clinical safetypreclinicalpreclinical efficacypreclinical safetysafety assessmentscaffoldscaffoldingstem cellssuidsurgerytransplanttumorigenesis
Sign up free to applyApply link · pipeline · email alerts
— or —

Get email alerts for similar roles

Weekly digest · no password needed · unsubscribe any time

Description preview

1. Production of GLP-grade iPSC lines and RPE from AMD patients.
Skin samples from three AMD patients were reprogrammed into GLP-grade iPSC lines and differentiated into RPE using a xeno-free medium. Generating lines from multiple patients demonstrated process consistency. The technology was successfully transferred to the NIH Clinical Center GMP…

🔒

Full details available on the Agency plan

Unlock the complete grant description, eligibility criteria, contract value, evaluation details and apply link — plus alerts, pipeline tracking, and CSV export.

Start 7-day free trial — $29.99/mo →

Agency Plan

7-day free trial

Unlock procurement & grants

Upgrade to access active tenders from World Bank, UNDP, ADB and more — with email alerts and pipeline tracking.

$29.99 / month

  • 🔔Email alerts for new matching tenders
  • 🗂️Track tenders in your pipeline
  • 💰Filter by contract value
  • 📥Export results to CSV
  • 📌Save searches with one click
Start 7-day free trial →